Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.20.4
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 108,856 $ 50,364
Trading account assets, pledged as collateral 91,510 90,946
Debt securities:    
Fair Value 448,180 219,821
Loans and leases, measured at fair value 6,681 8,335
Loans held for sale, measured at fair value 1,585 3,709
Other assets, measured at fair value 15,718 15,518
Deposits in U.S. offices:    
Interest bearing, measured at fair value 481 508
Federal funds purchased and securities loaned or sold under agreements to repurchase, measured at fair value 135,391 16,008
Short-term borrowings, measured at fair value 5,874 3,941
Accrued expenses and other liabilities, measured at fair value 16,311 15,434
Accrued expenses and other liabilities, reserve for unfunded lending commitments 1,878 813
Long-term debt, measured at fair value $ 32,200 $ 34,975
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 3,931,440 3,887,440
Preferred stock outstanding (in shares) 3,931,440 3,887,440
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 8,650,814,105 8,836,148,954
Common stock outstanding (in shares) 8,650,814,105 8,836,148,954
Short-term borrowings | Consolidated VIEs    
Shareholders’ equity    
Non-recourse debt $ 22 $ 0
Long-term debt | Consolidated VIEs    
Shareholders’ equity    
Non-recourse debt 7,053 8,717
Other liabilities | Consolidated VIEs    
Shareholders’ equity    
Non-recourse debt $ 16 $ 19